Evaluation Platforms for Diagnostic Materials and Assays
EXIMIO uses multiple evaluation platforms to support the assessment of diagnostic raw materials, reagent combinations and assay formulations throughout development.
ELISA, lateral flow immunoassay and Bio-Layer Interferometry provide complementary approaches for reviewing material performance, molecular interactions and practical assay behavior.
Plate-based evaluation for antigen-antibody and immunoassay performance.
Practical evaluation using colloidal gold and fluorescent conjugate systems.
Real-time, label-free analysis of molecular interactions.
Three Platforms, Different Technical Perspectives
Different stages of diagnostic development require different evaluation approaches. These platforms can support material screening, reagent comparison, assay development and molecular interaction analysis according to project requirements.
ELISA Platform
Supports plate-based evaluation of immunoreactivity and relevant antigen-antibody performance during material assessment.
Lateral Flow Platform
Supports practical assay evaluation through colloidal gold and fluorescent conjugate-based lateral flow systems.
BLI Platform
Supports real-time and label-free molecular interaction analysis, including association, dissociation and comparative affinity evaluation.
ELISA Evaluation Platform
ELISA provides a familiar plate-based approach for evaluating antigen-antibody reactions and immunoassay-related material performance.
The platform can be used during material screening and comparison where plate-based signal evaluation is appropriate for the development project.
Antigen-antibody reactivity evaluation
Candidate material comparison
Immunoassay-oriented screening support

Lateral Flow Immunoassay Platform
Lateral flow evaluation allows diagnostic materials and formulations to be reviewed directly within a rapid test format.
EXIMIO's evaluation capability includes both colloidal gold and fluorescent conjugate approaches, allowing different signal systems to be considered according to the assay.
Colloidal Gold Conjugates Platform
Supports lateral flow evaluation using colloidal gold-based signal generation and conjugate systems.
Fluorescent Conjugates Platform
Supports lateral flow evaluation using fluorescent conjugates where this signal format is suitable for the project.

Bio-Layer Interferometry
Bio-Layer Interferometry provides quantitative and dynamic information about molecular interactions through real-time, label-free analysis.
This provides another perspective for evaluating diagnostic biomaterials before or alongside downstream assay development.

Label-Free Analysis
Molecular interactions can be evaluated without introducing a conventional labeling step into the interaction being measured.
Real-Time Interaction Monitoring
Association and dissociation behavior can be observed over time rather than relying only on a single endpoint measurement.
Dip-and-Read Format
Sensor-based measurement provides a practical approach for interaction analysis across relevant biomaterial samples.
Molecular Interaction Evaluation
BLI can be incorporated into suitable projects where molecular interaction information can support reagent screening, characterization or diagnostic development decisions.
Molecular Interaction Evaluation
Review whether a measurable interaction occurs between selected molecular partners.
Modified Protein Analysis
Support comparative analysis of relevant modified protein samples where interaction behavior is important.
Antibody Evaluation
Support antibody screening, paired antibody screening, clone comparison and antigen-antibody affinity evaluation.
Protein–Polypeptide Interactions
Evaluate relevant interaction behavior between proteins and polypeptide targets.
Protein–Virus / Bacteria Interactions
Support relevant molecular interaction studies involving proteins and viral or bacterial targets.
Protein–DNA / RNA Interactions
Evaluate suitable interaction systems involving proteins and nucleic-acid targets.
Protein–Nanoparticle Interactions
Support interaction analysis between selected protein materials and nanoparticle systems.
Binding Site Research
Provide molecular interaction information that may support project-specific binding studies.
From Molecular Interaction to Practical Assay Performance
No single analytical platform answers every development question. Different evaluation methods can provide complementary information depending on the material and project stage.
Compare relevant candidate reagents and materials.
Review molecular interaction behavior where appropriate.
Evaluate selected materials within relevant assay formats.
Use evaluation results to guide subsequent development work.
Need evaluation support for your diagnostic materials?
Contact EXIMIO to discuss ELISA, lateral flow, BLI or other project-specific material evaluation requirements.